Japan has a severe shortage of arable land, covering only 11.3% of Japan’s total territory. The country’s self-sufficiency rate currently stands at 39%.
Japan has a severe shortage of arable land, covering only 11.3% of Japan’s total territory. The country’s self-sufficiency rate currently stands at 39%.
With an ever-increasing number of bio-ventures and the establishment of a new ecosystem in the Japanese biotech field, this sector offers many opportunities for European SME companies.
With Asia’s largest bioinformatics database located in Japan, the sector will be of an increasing importance, especially with its application to the medical and pharmaceutical industries.
BioJapan is Asia’s premier partnering event for the international biotechnology industry...
Japan is the third largest pharmaceutical market in the world, and the biologically active substances (biopharmaceuticals) are considered to be the driving force behind innovation in this industry.
In 2020, the Japanese agricultural biotechnology market was valued at about 615 billion yen. Japan remains one of the world’s largest per-capita importers of food and feed produced using modern biotechnologies.
Only a few weeks left to apply for the next Biotech training mission in Japan!You are an...
HEALTHCAPITAL - from DEHealthCapital Berlin-Brandenburg is the principal healthcare sector...
OcellO – from NLOcellO B.V. was founded in 2011 in Leiden. It is a privately owned...
Protobios – from EE Protobios Ltd. was founded in 2003. The company is developing new...
About the Report Japan being one of the leading countries in the biotechnology sector with...
About the Report This report presents an overview of the Biotechnology market in Japan...
About the ReportThis report provides an overview of the agricultural biotechnology sector...
About the ReportThis report is primarily concerned with developments, market trends and...
About the Report Japan is one of the major countries that European biotech companies...
About the report:This report titled 'Japanese Competence Centers in Bioinformatics and...
About the Report Japan spends consistently over 3% of its GDP on R&D, of which some 70%...
About the Report: The Japanese market for pharmaceuticals is amongst the largest in the...
About the Report: This report titled "Japan’s model for a bioeconomy - a primer for...
About the Report This report is an updated edition of a first study on cell technology...